Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Long term use of clopidogrel for patients with stents or acute coronary syndrome: a review of clinical and cost-effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2013 Authors' conclusions There appears to be uncertainty regarding the effectiveness of use of clopidogrel beyond one year. Results from the included studies were inconsistent and the majority of the studies were retrospective. In the evidence based guidelines there were no strong recommendations for use of clopidogrel beyond one year. Indexing Status Subject indexing assigned by CRD MeSH Acute Coronary Syndromes; Anticoagulants; Platelet Aggregation Inhibitors; Stents; Ticlopidine Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000104 Date abstract record published 23/01/2014 |